This company is a complete shamble.
Complete mismanagement of funds with no growth prospects domestically or internationally. Net loss of 7.4mil with no free cash flow. Numbers from the effect of
cronovirus haven’t even been considered yet...
Over weighted in assets with a bunch of loss making companies.
The end is nigh for Exp Co and after a number of reports of sham contracting of their employee I wouldn’t be surprised if it was embroiled with issues from Casa.
Get out why you still can.
- Forums
- ASX - By Stock
- EXP
- Ann: 1H20 Appendix 4D and Interim Financial Report
EXP
experience co limited
Add to My Watchlist
0.00%
!
12.0¢

Ann: 1H20 Appendix 4D and Interim Financial Report, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.89M |
Open | High | Low | Value | Volume |
12.0¢ | 12.3¢ | 12.0¢ | $6.67K | 55.54K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 141471 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 131227 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 141471 | 0.120 |
3 | 107270 | 0.110 |
2 | 47099 | 0.105 |
7 | 330000 | 0.100 |
1 | 50000 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 131227 | 1 |
0.135 | 106890 | 2 |
0.155 | 2 | 1 |
0.160 | 22727 | 1 |
0.165 | 51704 | 1 |
Last trade - 15.59pm 04/07/2025 (20 minute delay) ? |
Featured News
EXP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online